Corcept Therapeutics, Inc. (CORT)
83.15
+0.17
(+0.20%)
USD |
NASDAQ |
Dec 09, 16:00
83.16
+0.02
(+0.02%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly): 9.32% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Gilead Sciences, Inc. | 39.21% |
| LeMaitre Vascular, Inc. | 28.44% |
| United Therapeutics Corp. | 42.36% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.00% |
| Return on Assets | 12.77% |
| Return on Invested Capital | 15.84% |
| Gross Profit Margin (Quarterly) | 97.79% |
| Operating Margin (Quarterly) | 4.92% |
| Return on Net Operating Assets | 112.8% |